Koers Genetron Holdings Limited
Aandelen
GTH
US37186H2094
Biotechnologie & Medisch Onderzoek
Vertraagde tijd
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
4,025 USD | +0,12% | +0,12% | +9,38% |
28/03 | New Genetron Holding Limited heeft de overname afgerond van Genetron Holdings Limited (NasdaqGM:GTH) | CI |
2023 | Sectorupdate: Gezondheidszorgaandelen donderdag stabiel vóór de klok | MT |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Si Zhen Wang
CEO | Chief Executive Officer | 48 | 01-01-15 |
Hai Yan
FOU | Founder | 57 | 01-01-15 |
Ce Xu
DFI | Director of Finance/CFO | 43 | 01-03-18 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Dian Kang
BRD | Director/Board Member | 76 | 01-06-20 |
Wing Kee Lau
BRD | Director/Board Member | 60 | 01-06-20 |
Shan Fu
BRD | Director/Board Member | 56 | 01-06-21 |
Naam | Gewicht | Volume | Vaira. 1 jan. | belegger rating |
---|---|---|---|---|
0.01% | 0 M€ | 0,00% | - | |
0.00% | 2 M€ | -.--% | ||
0.00% | 117 M€ | +1,11% | - |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+1,51% | 42,59 mld. | |
+8,57% | 40,65 mld. | |
+49,22% | 40,57 mld. | |
-12,36% | 26,77 mld. | |
+8,92% | 24,81 mld. | |
-25,13% | 18,17 mld. | |
+29,17% | 12,05 mld. | |
-3,12% | 11,7 mld. | |
+6,35% | 11,1 mld. |